Clinical Trials Browser

INDUSTRY × Observational × Chemotherapy-induced Thrombocytopenia × Clear all

NCT03049774 2017-02-10

A Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor

Classical hematology

Chemotherapy-induced Thrombocytopenia